Cost-effectiveness of ribavirin interferon alfa-2B after interferon relapse in chronic hepatitis C.

被引：0
|
作者：
Wong, JB
Davis, GL
Pauker, SG
机构：
[1] Tufts New England Med Ctr, Div Clin Decis Making, Boston, MA USA
[2] Univ Florida, Dept Med, Sect Hepatobiliary Dis, Gainesville, FL USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1713
引用
收藏
页码：591A / 591A
页数：1
相关论文
共 50 条
  • [1] Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C
    Wong, JB
    Davis, GL
    Pauker, SG
    AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 366 - 373
  • [2] Estimating the cost-effectiveness of ribavirin and pegylated interferon alfa-2B for chronic hepatitis C.
    Wong, JB
    HEPATOLOGY, 2000, 32 (04) : 425A - 425A
  • [3] Cost-effectiveness of initial ribavirin interferon alfa-2B for chronic hepatitis C
    Wong, J
    McHutchinson, JG
    Poynard, T
    Ling, MH
    Albrecht, HK
    Pauker, SD
    GASTROENTEROLOGY, 1999, 116 (04) : A1289 - A1289
  • [4] Cost-effectiveness of ribavirin and pegylated interferon alfa-2b for initial treatment of chronic hepatitis C.
    Wong, JB
    Siebert, U
    Manns, MP
    McHutchison, JG
    Sroczynski, G
    Wasem, J
    Ravens-Sieberer, U
    Rossol, S
    Ling, MH
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 691A - 691A
  • [5] Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in Sweden
    Sennfält, K
    Reichard, O
    Hultkrantz, R
    Wong, JB
    Jonsson, D
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (08) : 870 - 876
  • [6] The cost-effectiveness analysis of peginterferon alfa-2a and ribavirin versus interferon alfa-2b and ribavirin in chronic hepatitis C in Poland
    Orlewska, E
    Juszczyk, J
    VALUE IN HEALTH, 2003, 6 (06) : 749 - 750
  • [7] Interferon alfa-2b and ribavirin in patients with resistant chronic hepatitis C.
    Min, AD
    Jones, JL
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Esposito, S
    Geders, JM
    Tobias, H
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
  • [8] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111
  • [9] Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
    Kim, WR
    Poterucha, JJ
    Gross, JB
    HEPATOLOGY, 2000, 31 (03) : 807 - 807
  • [10] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    Davis, GL
    Esteban-Mur, R
    Rustgi, V
    Hoefs, J
    Gordon, SC
    Trepo, C
    Shiffman, ML
    Zeuzem, S
    Craxi, A
    Ling, MH
    Albrecht, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1493 - 1499
12345